Form D · Biotechnology
REDOX PHARMACEUTICAL CORP
Greenvale, NY · CIK 0000899341
Offering snapshot reported Jan 11, 2010 · SEC filing
- Reported sold
- $123K Offering amount: $2.35M
- Investors reported
- 44 Form D · investor count
- Minimum accepted
- $200 Reported outside-investor minimum
- First sale
- Oct 18, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 11, 2010 | Initial | $123,200 | No comparison | 44 | SEC filing |
| Aug 1, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 24, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-89934-1N
The offering expired 12/31/2009. No additional shares will be purchased
None
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Jan 11, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donald Brown | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Forest Drive
Greenvale, NY, 11548
Greenvale, NY, 11548